Bioactive materials developed through three-dimensional (3D) bioprinting technology
exhibit static nature and don't respond to the dynamic changes occurred in the human body …

Abstract 3D bioprinting or additive manufacturing is an emerging innovative technology
revolutionizing the field of biomedical applications by combining engineering …

The advancement of tissue engineering for regenerating injured tissues and organs has
progressed significantly in recent years. Various techniques have been used to modify the …

The limitations of traditional two-dimensional (2D) cultures and animal testing, when it
comes to precisely foreseeing the toxicity and clinical effectiveness of potential drug …

Drug development and testing are a tedious and expensive process with a high degree of
uncertainty in the clinical success and preclinical validation of manufactured therapeutic …

Additive Manufacturing (AM) has recently demonstrated significant medical progress. Due to
advancements in materials and methodologies, various processes have been developed to …

Gelatin Methacryloyl (GelMA) is one of the most used biomaterials for a wide range of
applications, such as drug delivery, disease modeling and tissue regeneration. GelMA is …

Granular synthetic hydrogels are useful bioinks for their compatibility with a variety of
chemistries, affording printable, stimuli‐responsive scaffolds with programmable structure …

Additive manufacturing, often known as three-dimensional (3D) printing, is driving significant
progress in a diverse range of fields, such as engineering, manufacturing, food, and …

Abstract 3D bioprinting is a promising technology to fabricate custom geometries for tissue
engineering. However, most bioprintable hydrogels are weak and fragile, difficult to handle …